Dionne Davis

741 total citations · 1 hit paper
10 papers, 472 citations indexed

About

Dionne Davis is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Dionne Davis has authored 10 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Dionne Davis's work include Glioma Diagnosis and Treatment (4 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Dionne Davis is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Dionne Davis collaborates with scholars based in United States, China and Germany. Dionne Davis's co-authors include Hua Song, Mark R. Gilbert, Jinkyu Jung, Deric M. Park, Heather M. Sonnemann, Caitlin Marie Reid, Nivedita M. Ratnam, Amber Giles, Marsha-Kay Hutchinson and Peter E. Fecci and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Investigative Ophthalmology & Visual Science.

In The Last Decade

Dionne Davis

9 papers receiving 468 citations

Hit Papers

Dexamethasone-induced immunosuppression: mechanisms and i... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dionne Davis United States 8 172 147 110 100 73 10 472
Marsha-Kay Hutchinson United States 5 217 1.3× 152 1.0× 117 1.1× 85 0.8× 88 1.2× 5 492
Caitlin Marie Reid United States 4 234 1.4× 116 0.8× 174 1.6× 87 0.9× 69 0.9× 5 479
Heather M. Sonnemann United States 4 183 1.1× 81 0.6× 130 1.2× 83 0.8× 57 0.8× 7 384
Fouzia Siraj India 13 117 0.7× 156 1.1× 72 0.7× 58 0.6× 62 0.8× 83 535
Kenneth B. Fallon United States 12 150 0.9× 159 1.1× 70 0.6× 141 1.4× 85 1.2× 19 504
Andrew Bantly United States 13 146 0.8× 294 2.0× 103 0.9× 59 0.6× 22 0.3× 19 538
Erhong Meng China 10 236 1.4× 296 2.0× 61 0.6× 48 0.5× 34 0.5× 24 571
Qi Yu China 13 82 0.5× 176 1.2× 73 0.7× 93 0.9× 73 1.0× 37 540
Delfina Costa Italy 16 192 1.1× 249 1.7× 175 1.6× 27 0.3× 54 0.7× 29 663
Vassilis Samaras Greece 12 116 0.7× 202 1.4× 89 0.8× 103 1.0× 52 0.7× 15 437

Countries citing papers authored by Dionne Davis

Since Specialization
Citations

This map shows the geographic impact of Dionne Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dionne Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dionne Davis more than expected).

Fields of papers citing papers by Dionne Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dionne Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dionne Davis. The network helps show where Dionne Davis may publish in the future.

Co-authorship network of co-authors of Dionne Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Dionne Davis. A scholar is included among the top collaborators of Dionne Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dionne Davis. Dionne Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Makranz, Chen, Meili Zhang, Dionne Davis, et al.. (2024). EXTH-12. POTENTIATING THE EFFICACY OF IMMUNE CHECK-POINT INHIBITORS IN GLIOBLASTOMA BY INHIBITION OF CXCL12. Neuro-Oncology. 26(Supplement_8). viii238–viii238. 1 indexed citations
2.
Liu, Yang, Fu-Ju Chou, Fengchao Lang, et al.. (2023). Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2. Clinical Cancer Research. 29(7). 1305–1316. 23 indexed citations
3.
Ratnam, Nivedita M., Heather M. Sonnemann, Huanwen Chen, et al.. (2021). Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies. Frontiers in Oncology. 11. 719091–719091. 19 indexed citations
4.
Ruiz‐Rodado, Victor, Adrian Lita, Tyrone Dowdy, et al.. (2020). Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition. SHILAP Revista de lepidopterología. 8(1). 23–23. 14 indexed citations
5.
Zhou, Yiqiang, Yang Liu, Junwen Zhang, et al.. (2019). Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas. Translational Oncology. 13(2). 125–134. 17 indexed citations
6.
Cao, Xiaoyu, Yanxin Lu, Yang Liu, et al.. (2019). Combination of PARP inhibitor and temozolomide to suppress chordoma progression. Journal of Molecular Medicine. 97(8). 1183–1193. 23 indexed citations
7.
Ruiz‐Rodado, Victor, Adrian Lita, Tyrone Dowdy, et al.. (2019). Metabolic Plasticity of IDH1- <i>Mutant</i> Glioma Cell Lines Is Responsible for Low Sensitivity to Glutaminase Inhibition. SSRN Electronic Journal.
8.
Giles, Amber, Marsha-Kay Hutchinson, Heather M. Sonnemann, et al.. (2018). Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. Journal for ImmunoTherapy of Cancer. 6(1). 51–51. 328 indexed citations breakdown →
9.
Larion, Mioara, Tyrone Dowdy, Victor Ruiz‐Rodado, et al.. (2018). Detection of Metabolic Changes Induced via Drug Treatments in Live Cancer Cells and Tissue Using Raman Imaging Microscopy. Biosensors. 9(1). 5–5. 22 indexed citations
10.
Davis, Janine, Dionne Davis, Barbara Norman, & Joram Piatigorsky. (2008). Gene Expression of the Mouse Corneal CrystallinAldh3a1: Activation by Pax6, Oct1, and p300. Investigative Ophthalmology & Visual Science. 49(5). 1814–1814. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026